Australia markets closed

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.32000.0000 (0.00%)
At close: 04:00PM EDT
1.3100 -0.01 (-0.76%)
After hours: 07:17PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-276,056
-276,056
-368,198
-523,837
-444,440
Depreciation & amortisation
7,815
7,815
13,030
14,146
14,182
Deferred income taxes
-140
-140
2,708
-102
-36
Stock-based compensation
33,388
33,388
57,320
94,674
94,261
Change in working capital
-19,800
-19,800
492
-22,974
16,748
Accounts receivable
4,776
4,776
16,511
12,397
1,913
Inventory
699
699
-3,401
-509
-2,627
Accounts payable
-2,884
-2,884
3,103
-11,690
2,382
Other working capital
-193,471
-193,471
-309,683
-427,649
-320,545
Other non-cash items
-43,587
-43,587
-35,932
10,680
-14,353
Net cash provided by operating activities
-192,606
-192,606
-304,007
-412,660
-313,287
Cash flows from investing activities
Investments in property, plant and equipment
-865
-865
-5,676
-14,989
-7,258
Purchases of investments
-511,699
-511,699
-467,914
-960,689
-987,533
Sales/maturities of investments
650,883
650,883
826,229
1,178,455
1,491,004
Net cash used for investing activities
139,564
139,564
365,835
202,777
496,213
Cash flows from financing activities
Debt repayment
-
-
0
0
-250,000
Common stock issued
-
-
-
-
0
Other financing activities
-
-
750
3,000
146,250
Net cash used provided by (used for) financing activities
30
30
1,508
36,238
-80,354
Net change in cash
-52,950
-52,950
63,009
-173,737
102,592
Cash at beginning of period
88,227
88,227
25,218
198,955
96,363
Cash at end of period
35,277
35,277
88,227
25,218
198,955
Free cash flow
Operating cash flow
-192,606
-192,606
-304,007
-412,660
-313,287
Capital expenditure
-865
-865
-5,676
-14,989
-7,258
Free cash flow
-193,471
-193,471
-309,683
-427,649
-320,545